The depletion of the neurotransmitter is responsible for AD symptoms, which is why cholinesterase inhibitors (such as rivastigmine, donepezil, tacrine (discontinued from 2013), and galantamine) are used to increase ACh levels. This evidence concerns the gene BCHE and Alzheimer disease.